Literature DB >> 5315769

Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.

G Bartholini, J Constantinidis, R Tissot, A Pletscher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5315769     DOI: 10.1016/0006-2952(71)90354-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  13 in total

1.  The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.

Authors:  H Altier; M Moldes; J M Monti
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

2.  Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentration in the human brain.

Authors:  O Benkert; G Laakmann; A Souvatzoglou; K von Werder
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

3.  Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

5.  Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserine.

Authors:  M Puig; G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Central decarboxylation and uptake of L-DOPA.

Authors:  N E Andén; J Engel; A Rubenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

8.  Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.

Authors:  J Constantinidis; J Siegfried; T L Frigyesi; R Tissot
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

9.  Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.

Authors:  P J Langlais; R G Mair; P J Whalen; W McCourt; W J McEntee
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Tryptophan and the control of plasma glucose concentrations in the rat.

Authors:  S A Smith; C L Pogson
Journal:  Biochem J       Date:  1977-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.